Association of CYP3A5 & #42;3 polymorphisms and prostate cancer risk: A meta-analysis

Conclusion: Our data support that the CYP3A5*3 polymorphism may be associated with increased risk of prostate cancer, particularly in African populations. Large and well-designed studies are needed to validate this association.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Source Type: research